Skip to main content
    S

    Strata Critical Medical, Inc. (SRTA)

    Official site

    HEALTHCARE • NONE • NASDAQ

    $4.45
    -0.09 (-1.98%)

    Market Cap: $378.64M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(15/21)
    Avg Surprise
    -63.28%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.05 - $0.01
    4 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.02+62.5%
    60d ago$-0.01+43.6%
    30d ago$-0.01+43.6%
    7d ago$-0.01+43.6%
    Current$-0.01
    Revenue Consensus
    $73M
    Range$71M - $74M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.03
    Range$-0.12 - $0.02
    4 analysts
    Revenue Consensus
    $87M
    Range$85M - $89M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.03---
    Sep 26EST
    		-$-0.01---
    Jun 26
    Reported Aug 4
    		$-0.01$-0.01+0.00%Beat+75.0%
    Mar 26
    Reported May 6
    		$0.04$-0.04+200.00%Beat+157.1%
    Dec 25
    Reported Mar 3
    		$-0.12$0.06-300.00%Miss+5.7%
    Sep 25
    Reported Nov 10
    		$-0.12$-0.02-500.00%Miss-1100.0%
    Jun 25
    Reported Aug 5
    		$-0.04$-0.05+20.00%Beat+33.3%
    Mar 25
    Reported May 12
    		$-0.07$-0.10+30.00%Beat+30.0%
    Dec 24
    Reported Mar 13
    		$-0.13$-0.12-10.60%Miss+1.7%
    Sep 24
    Reported Nov 12
    		$-0.01$-0.02+50.00%Beat+50.0%
    Jun 24
    Reported Aug 7
    		$-0.06$-0.06+0.00%Beat+33.3%
    Mar 24
    Reported May 7
    		$-0.10$-0.11+9.09%Beat+28.6%
    Dec 23
    Reported Mar 12
    		$-0.13$-0.12-7.92%Miss+41.1%
    Sep 23
    Reported Nov 8
    		$-0.02N/A+66.67%Beat+77.8%
    Jun 23
    Reported Aug 9
    		$-0.09$-0.10+10.00%Beat+18.2%
    Mar 23
    Reported May 11
    		$-0.14$-0.16+12.50%Beat+6.7%
    Dec 22
    Reported Mar 15
    		$-0.22$-0.20-10.00%Miss-69.2%
    Sep 22
    Reported Nov 10
    		$-0.09$-0.13+30.77%Beat+80.9%
    Jun 22
    Reported Aug 9
    		$-0.11$-0.19+42.11%Beat+66.8%
    Mar 22
    Reported May 10
    		$-0.15$-0.20+25.00%Beat+6.3%
    Sep 21
    Reported Dec 20
    		$-0.13$-0.14+7.14%Beat-1200.0%
    Jun 21
    Reported Aug 16
    		$-0.47$-0.47+0.00%Beat-234900.0%
    Mar 21
    Reported May 17
    		$-0.33$-0.03-1003.67%Miss-573.0%
    Dec 20
    Reported Mar 10
    		$-0.16N/AN/ABeat-328.6%
    Sep 20
    Reported Nov 10
    		$-0.01N/AN/ABeat-150.0%
    Jun 20
    Reported Aug 13
    		$-0.00N/AN/ABeat-
    Mar 20
    Reported May 13
    		$0.07N/AN/ABeat-
    Dec 19
    Reported Mar 20
    		$0.07N/AN/ABeat-
    Sep 19
    Reported Nov 13
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-21.19EV/EBITDAN/A
    Price/FCF-8.78xFCF Yield-11.39%
    Profitability
    Profit Margin15.70%Operating Margin-6.32%
    ROE-9.22%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio2.64xQuick Ratio2.64x
    Trading Statistics
    Beta2.43Avg Volume815.51K
    52-Week High$6.5052-Week Low$3.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.69
    SMA 20$5.00
    SMA 50$5.43
    SMA 200$5.15
    EMA 10$4.69
    EMA 20$4.91
    EMA 50$5.20
    EMA 200$5.18

    MACD

    Line: -0.26Signal: -0.21Hist: -0.05

    ADX

    ADX: 43.4+DI: 5.7-DI: 29.1

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down92.0
    PSAR$4.87

    Bollinger Bands

    Upper Band$5.72
    Lower Band$4.29
    %B Position2853%(Upper)
    Band Width0.11

    RSI (14-Day)

    Oversold
    28.1

    Momentum Oscillators

    Stoch %K9.7
    Stoch %D7.9
    Williams %R-95.0
    ROC (10d)-12.7%
    Momentum-0.65
    CCI (20d)-111.5
    MFI (14d)20.1

    Volatility Measures

    ATR (14d)$0.20(4.4%)
    StdDev (20d)0.36
    Hist Vol33.9%(Moderate)

    Volume Flow

    VWAP$4.49
    OBV-4.8M
    AD Line-14.6M
    CMF (20d)-0.260

    Volume Metrics

    Avg Vol (20d)812.2K
    Vol Ratio0.7x
    VWMA (20d)$4.97

    Pivot Points

    R3$4.75
    R2$4.67
    R1$4.61
    Pivot Point$4.53
    S1$4.46
    S2$4.38
    S3$4.32

    Advanced Oscillators

    TSI-34.84
    Ultimate Osc36.3
    KST-142.19

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$72.51M$67.38M$66.79M$49.30M$70.80M$54.31M$54.36M$74.88M$67.94M$51.51M$47.48M$71.44M
    Cost of Revenue$57.29M$53.27M$55.12M$37.68M$53.06M$42.33M$41.77M$55.04M$51.59M$41.38M$38.47M$55.86M
    Gross Profit$15.21M$14.12M$11.67M$11.61M$17.74M$11.98M$12.59M$19.84M$16.35M$10.14M$9.01M$15.58M
    Operating Expenses$20.62M$17.09M$18.07M$17.24M$22.69M$19.56M$20.96M$23.37M$28.50M$20.01M$44.64M$23.03M
    R&D$1.01M$1.12M$1.70M$453,000$915,000$812,000$743,000$800,000$971,000$670,000$988,000$1.08M
    SG&A$8.82M$15.61M$16.82M$16.30M$20.14M$17.31M$18.95M$20.41M$25.14M$17.21M$41.24M$19.27M
    Operating Income$-5,408,000$-2,974,000$-6,405,000$-5,622,000$-4,954,000$-7,583,000$-8,372,000$-3,537,000$-12,149,000$-9,868,000$-35,633,000$-7,448,000
    Interest Income$331,000$473,000$638,000$1.13M$1.16M$1.32M$1.59M$1.76M$1.79M$0$0$0
    Interest Expense$5.11M$0$0$4.04M$0$0$1.53M$0$0$0$0$0
    Income Before Tax$-10,516,000$2.40M$-5,388,000$-9,657,000$-3,722,000$-3,510,000$-9,898,000$-2,072,000$-11,274,000$-4,318,000$-34,964,000$418,000
    Income Tax Expense$0$248,000$3.44M$-64,862,000$21,000$-17,000$-105,000$-118,000$52,000$-84,000$-1,023,000$129,000
    Net Income$-10,516,000$2.15M$-8,833,000$57.42M$-3,743,000$-3,493,000$-9,793,000$-1,954,000$-11,326,000$-4,234,000$-33,941,000$289,000
    EBITDA$-2,001,000$1.16M$-558,000$-7,953,000$-1,946,000$-1,813,000$-8,368,000$-793,000$-9,715,000$-2,724,000$-33,158,000$2.26M
    EBIT$-10,516,000$-1,905,000$-3,566,000$-9,657,000$-3,722,000$-3,510,000$-9,898,000$-2,072,000$-11,274,000$-4,318,000$-34,964,000$418,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SRTA

    News

    A shareholder says Strata Critical Medical (SRTA) should explore a potential sale.

    Third Point LLC and Daniel S. Loeb have reported a 5.8% beneficial ownership stake in Strata Critical Medical (SRTA) through a Schedule 13D filing. They believe the company's common stock is undervalued and that its...

    Stock Titan•10/15/26•Somewhat-Bullish

    Daniel S. Loeb Pushes for Changes at Strata Critical Medical with 5.8% Stake

    Daniel S. Loeb, through Third Point LLC, has taken a 5.8% active stake in Strata Critical Medical (SRTA), pushing for strategic changes. He believes the stock is undervalued and the company's current structure...

    TradingView•10/15/26•Bullish

    Strata Critical Medical Q2 2026 Earnings Call Transcript

    Strata Critical Medical (NASDAQ: SRTA) reported strong Q2 2026 results with a 60.7% year-over-year revenue increase to $72.5 million...

    Benzinga•9/28/26•Somewhat-Bullish

    Form 4 Strata Critical Medical Inc For: 26 September By Investing.com

    This article reports on a Form 4 filing for Strata Critical Medical Inc. on September 26, 2026. The piece is brief and contains primarily market data and other news headlines from Investing.com...

    Investing.com Nigeria•9/26/26•Neutral

    Performance targets were met. Strata Critical Medical (SRTA) co-CEO acquired 177,858 shares.

    Strata Critical Medical's Co-CEO and CFO, William A. Heyburn, acquired 177,858 shares of Class A common stock on September 24, 2026, after performance criteria for restricted stock units were met. Simultaneously...

    Stock Titan•9/25/26•Neutral

    SRTA Valuation and Fair Value

    P/E
    -21.2x
    Forward P/E
    138.9x
    P/FCF
    -8.8x
    P/B
    1.4x
    See GNG's fair value

    SRTA Profitability: Margins, ROIC and FCF

    Gross margin
    20.6%
    Operating margin
    -6.3%
    Net margin
    15.7%
    ROE
    -9.2%
    FCF margin
    -17.1%
    FCF yield
    -11.4%

    SRTA Competitors

    CompanyTicker
    I-MabIMAB
    Carlsmed, Inc.CARL
    TruBridge Inc.TBRG
    Editas Medicine IncEDIT
    ARS Pharmaceuticals, IncSPRY
    Simulations Plus IncSLP
    Myriad Genetics IncMYGN
    Orthofix Medical IncOFIX

    Sector: Healthcare

    SRTA Analyst Ratings

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    0
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0

    SRTA Bull Case vs Bear Case

    Bull case

    • SRTA grew quarterly revenue 60.7% year over year.

    SRTA Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -63.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About SRTA

    Does SRTA pay dividends?

    Strata Critical Medical, Inc. (SRTA) does not currently pay a regular dividend.

    What is SRTA's market cap?

    Strata Critical Medical, Inc. (SRTA) has a market capitalization of $378.64M with a current stock price of $4.45.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In